Agoracom Blog Home

Posts Tagged ‘otc’

NORTHBUD $NBUD.ca – Brace for Impact: Industries on the Verge of #CBD Disruption $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 1:20 PM on Tuesday, December 10th, 2019

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

NORTHBUD $NBUD.ca – #Cannabis sector mounts furious lobbying drive in Ontario; Hillier seeks clarity $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 4:50 PM on Friday, November 22nd, 2019

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

Cannabis sector mounts furious lobbying drive in Ontario; Hillier seeks clarity

  • Over the past month, lobbyists have beat a path to Ontario’s legislature to discuss – among other things related to cannabis – taxation, labor policies, law enforcement and how adult-use marijuana is sold in the province

By Matt Lamers

Punished by disappointing sales due to a lack of retail stores, the cannabis industry has been mounting a fierce lobbying drive in Ontario to reach the decisionmakers driving the province’s marijuana policies, according to records from the Office of the Integrity Commissioner.

Over the past month, lobbyists have beat a path to Ontario’s legislature to discuss – among other things related to cannabis – taxation, labor policies, law enforcement and how adult-use marijuana is sold in the province.

The records show that efforts have been made to reach Ontario’s power brokers by:

  • Aurora Cannabis
  • Aphria
  • Convenience Industry Council of Canada
  • Cronos Group
  • The Green Organic Dutchman
  • Insurance Bureau of Canada
  • LeafLink
  • Loblaw
  • Supreme Cannabis Co.
  • Truss

Meanwhile, a former member of the ruling Progressive Conservative caucus is urging the party to adopt a clearer timeline for the planned pivot to an open allocation of adult-use retail stores.

Independent MPP Randy Hillier said Ontario’s bungled cannabis policies are costing the province, and its businesses, millions in lost economic opportunities.

“Here we have a government that promotes itself as ‘open for business,’ and what is the biggest impediment in the cannabis trade right now? Government’s lack of action and preventing people (from) opening retail establishments,” the independent MPP said in an interview.

He called Ontario’s cannabis lottery a “cluster you-know-what.”

The fledgling industry has already lost out on hundreds of millions of dollars of revenue, according to Craig Wiggins, managing director of market researcher TheCannalysts.

That has caused some producers to scale back production.

Hillier called on the government to empower the Alcohol and Gaming Commission of Ontario to license cannabis stores.

“We have 24 stores in operation a year out from legalization to serve 14 million people,” he said. “Newfoundland, with a population of 500,000 people, has as many stores as Ontario. Saskatchewan has twice as many with a population of a million people.

“We’re not achieving what we set out to with the legalization of cannabis, which is to get it out of the criminal marketplace. We’re allowing the criminal marketplace to continue to thrive.”

Ontario’s recent Economic Outlook restated the commitment to “an open allocation of cannabis retail store licenses where the number of stores is limited only by market demand,” however no timeline was offered.

Hillier’s advice to legal cannabis businesses is to speak up.

“If government policies are creating barriers for your businesses, then speak out.

“Bark as loud as possible, and possibly bite. That’s what often motivates government, is fear of embarrassment and fear of having to justify their actions.”

Matt Lamers is Marijuana Business Daily’s international editor, based near Toronto, Ontario. He can be reached at [email protected].

Source: https://mjbizdaily.com/cannabis-sector-mounts-furious-lobbying-drive-in-ontario-hillier-demands-clarity/

NORTHBUD $NBUD.ca – Top 10 #Marijuana Industry News Stories $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 2:44 PM on Monday, November 11th, 2019

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

NBUD: CSE
—————————–

Top 10 Marijuana Industry News Stories

Cannabis Countdown: Top 10 Marijuana Industry News Stories of the Week

Welcome to the Cannabis Countdown. In this week’s rendition, we’ll recap and countdown the top 10 marijuana industry news stories for the week of November 4th – 10th, 2019.

Without further ado, let’s get started.

10. Drake’s Next Act: “Potline Bling” Feat. Canopy Growth Corp

Multi-Platinum Recording Superstar Drake and Canopy Growth Announce New Cannabis Partnership

Drake is heading home and will own a majority stake in Toronto-based “More Life Growth”. Canopy Growth (TSX: WEED) (NYSE: CGC) will own the remaining 40% in the new fully licensed cannabis producer.

READ FULL DRAKE ARTICLE

9. Passengers Carrying Cannabis on Air Canada’s Toronto to Vancouver Flight Shocked When Plane Got Re-Routed to U.S.

Foggy Conditions Forced Flight AC 125 to Land at Seattle Airport with Some Passengers Carrying Cannabis and CBD

One legal expert gives advice to Canadians on how to handle an extraordinary situation like this.

READ FULL AIR CANADA ARTICLE

8. Mexico Has Until April 30 to Legalize Cannabis, Supreme Court Rules

That Legislation Proposed Rules Limiting Foreign Ownership, Vertical Integration and License Resale

Mexico’s Supreme Court gave Congress another six months to approve legislation that legalizes all forms of cannabis, postponing until the end of April the deadline for when the Latin American country would create the world’s largest adult-use market by population.

READ FULL MEXICO ARTICLE

7. Canopy Growth Downsizes Latin America Workforce as Region Struggles to Generate Revenue

Investors Have Sent a Clear Message They Want Companies to be More Prudent in Their Spending

One of the largest cannabis companies in the world, Canopy Growth (TSX: WEED) (NYSE: CGC), is restructuring its overseas operations by laying off 15% of its workforce in Latin America, reflecting the slow pace at which revenue-generating opportunities and regulatory structures are evolving in the region.

READ FULL CANOPY GROWTH ARTICLE

6. FDA Won’t be Hurried to Create CBD Exceptions Amid Safety Concerns

The Agency’s Biggest Concern is Whether CBD is Safe to Consume in Food and Supplements

A top official for the U.S. Food and Drug Administration (FDA) said the agency is concerned that developing a legal exception for supplements containing CBD could send the wrong message, both to companies interested in entering the market and consumers.

READ FULL FDA CBD ARTICLE

5. Ontario Business Group Wants ‘Clear Timeline’ for Cannabis Store Expansion

So Far, Ontario Has Used a Botched Lottery System to Award Licenses to Open Recreational Marijuana Stores

A group comprised of cannabis industry leaders and experts is calling on Ontario’s government to provide a more complete timetable for when retail stores will be permitted through an open allocation of licenses.

READ FULL ONTARIO ARTICLE

4. Michigan Nets 52 Adult-Use Marijuana Applications on First Day

State Regulators Expect the First License to be Issued Before the End of November

Marijuana regulators in Michigan received 52 recreational cannabis business license applications on the first day of the application period.

READ FULL MICHIGAN ARTICLE

3. Cannabis Canada: Pot Industry Added Nearly Billion to GDP in August

Cannabis Sales in Canada Expected to Double Next Year to $3.16 Billion

Canaccord Genuity cannabis analyst Matt Bottomley expects revenue in Canada’s legal pot sector to more than double next year despite slower-than-expected growth. Bottomley said in a research note to clients that Canada’s cannabis industry should expect $3.16 billion in revenue in 2020, up from the $1.46 billion forecast for 2019.

READ FULL CANADA STATS ARTICLE

2. U.S. Senate Approves Legislation Protecting State-Legal Medical Cannabis Programs from Federal Interference

Supporters Hope Similar Protection for Recreational States Will Be Included in Final Version Sent to President Trump

The U.S. Senate passed a spending bill extending a provision that protects medical cannabis states from federal interference. It’s unknown if the broader House approved protections for adult-use state cannabis programs will be included in the final version of the bill that’s passed along to President Trump.

READ FULL MMJ SENATE ARTICLE

1. Breakthrough in CDC Vape Crisis Investigation

Vitamin E Acetate Linked to THC May Be to Blame

Vitamin E acetate, an additive sometimes used in THC and other vaping products, may be to blame for a national vape crisis of e-cigarette-related lung injuries that’s linked to dozens of deaths, according to U.S. Centers for Disease Control and Prevention officials.

Source: https://finance.yahoo.com/news/cannabis-countdown-top-10-marijuana-141349361.html

North Bud Farms $NBUD.ca Announces Annual General and Special Meeting on December 16th and the Closing of the First Tranche of its Non-Brokered Private Placement of Secured Convertible Debenture Units $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 4:50 PM on Wednesday, November 6th, 2019
  • Annual General and Special Meeting at 1:00 p.m. on Monday, December 16, 2019 at the office of McMillan LLP World Exchange Plaza, Suite 2000, Ottawa, Ontario.  
  • Announce that on November 6, 2019, the board authorized the issuance of up to 4,000 convertible debenture units of the Company at a price of $1,000 per Unit for total gross proceeds of up to $4,000,000.

TORONTO, Nov. 06, 2019 — North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) (“NORTHBUD” or the “Company”) today announces that the Company will hold its Annual General and Special Meeting at 1:00 p.m. on Monday, December 16, 2019 at the office of McMillan LLP World Exchange Plaza, Suite 2000, Ottawa, Ontario.  

Additionally, the Company is pleased to announce that on November 6, 2019, the board authorized the issuance of up to 4,000 convertible debenture units (“Units”) of the Company at a price of $1,000 per Unit for total gross proceeds of up to $4,000,000. Based on this decision the Company will not be closing any additional tranches of the previously announced equity private placement.

Each Unit is comprised of one $1,000 principal amount of secured convertible debenture (a “Convertible Debenture”) accruing interest at 10.0% per annum, payable semi-annually in arrears until maturity, and 2,000 common share purchase warrants of the Company (each, a “Warrant”). The Convertible Debentures will have a maturity date of 36 months from the date of issuance.

Each Convertible Debenture shall be convertible into common shares in the capital of the Company (each, a “Conversion Share”) at a price of $0.30 per Conversion Share.

Each Warrant entitles the holder thereof to acquire one common share in the capital of the Company (each, a “Warrant Share”) for an exercise price of $0.25 per Warrant Share for a period of 18 months following the closing date.

The Convertible Debentures are direct secured obligations of the Company and rank pari passu in right of payment of principal and interest with all other Convertible Debentures issued under the Offering.

The Company is pleased to announce that on November 6, 2019 it closed an initial tranche of 1,264 Units for gross proceeds of $1,264,000. These Units were purchased by one insider and existing shareholders. The Company intends to close the remaining Units in one or more tranches over the coming weeks.

Ryan Brown, the Chief Executive Officer, of the Company participated in the private placement and beneficially acquired 664 Units for a total proceeds of $664,000. The purchase constitutes a “related party transaction” within the meaning of Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101”). The issuance is exempt from the formal valuation and minority shareholder approval requirements of MI 61-101 as the fair market value of the Units issued to or the consideration paid by such insider did not exceed 25% of the Company’s market capitalization.

Certain finders (the “Finders”) received a cash commission on the sale of the Offering of $48,000. The Finders also received 48,000 compensation warrants (the “Compensation Warrants”), each carrying the right to purchase 3.3333 common shares in the capital of the Company at a price of $1.00 per Compensation Warrant for a period of 18 months from the closing date.

The proceeds of the Offering will be used by the Company for expansion of the Company’s facilities and for general corporate and working capital purposes.

The Convertible Debentures, Warrants and Compensation Warrants issued pursuant to the Offering and any common shares in the capital of the Company issued on conversion of the Convertible Debentures or exercise of the Warrants or Compensation Warrants are subject to a statutory hold period in Canada of four months and one day following the closing date in accordance with applicable securities laws, which shall expire on March 7, 2020. Additional resale restrictions may be applicable under the laws of other jurisdictions, if any.

The securities of the Company have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws. Accordingly, the securities of the Company may not be offered or sold within the United States unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws. This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities of the
Company in any jurisdiction in which such offer, solicitation or sale would be unlawful.

Corporate Update
Since the submission of our evidence package to Health Canada, the Company has received some minor comments from the regulators all of which have been responded to within 24 hours. The Company will update shareholders with any material developments related to the application process.

About North Bud Farms Inc.
North Bud Farms Inc., through its wholly owned subsidiary GrowPros MMP Inc., is pursuing a licence under The Cannabis Act.  The Company has built a state-of-the-art purpose-built cannabis production facility located on 135 acres of Agricultural Land in Low, Quebec, Canada. NORTHBUD through its wholly owned U.S. subsidiary, Bonfire Brands USA has entered into agreements to acquire assets in California and Nevada.

For more information visit: www.northbud.com

Neither the Canadian Securities Exchange (the “CSE”) nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements
Certain statements included in this press release constitute forward-looking information or statements (collectively, “forward-looking statements”), including those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management. The forward-looking statements are not historical facts but reflect current expectations regarding future results or events. This press release contains forward- looking statements that include, but are not limited to, statements related to the intended use of proceeds from the Offering. These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors. Such risks and uncertainties include, among others, the risk factors included in North Bud Farms Inc.’s final long form prospectus dated August 21, 2018, which is available under the issuer’s SEDAR profile at www.sedar.com

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
North Bud Farms Inc.
Edward Miller
VP, IR & Communications
Office: (855) 628-3420 ext. 3
[email protected] 

NORTHBUD $NBUD.ca – #Edible #CBD Products Offer Consumers a New Health Trend $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 4:00 PM on Thursday, October 31st, 2019

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

NBUD: CSE
—————————–

Edible CBD Products Offer Consumers a New Health Trend

  • North American consumer spending on cannabis-infused foods and drinks reached USD 1.5 Billion in 2018, according to data compiled by Arcview Market Research and BDS Analytics,
  • By 2022, the two firms suggest that edible sales are on track to reach USD 4.1 Billion

NEW YORK, Oct. 31, 2019 – Consumer trends constantly require industries to adapt in order to thrive among the competition. Specifically, the food and beverage industry is one of the fastest evolving markets because of constant changes in consumer demands. Nowadays, the increasing demand for healthier and more organic options is prompting manufacturers to produce alternatives to sugar-packed drinks and fatty snacks. Instead, consumers are looking for products that are processed with healthier sustainable ingredients, proteins, vitamins, and antioxidants. Notably, many consumers have turned to the beverage industry for functional drinks such as kombucha. A functional drink is a type of beverage that typically conveys a health benefit such as being packed with performance-enhancing agents like nootropics and amino acids. Consequently, the growing demand in the functional beverage market sparked interest within the CBD market. CBD is a derivative of the hemp plant, which falls under the cannabis family.

Typically, cannabis is associated with its marijuana component, which causes psychoactive effects because of its heavy THC concentrate. However, hemp does not cause psychoactive effects because the main compound is CBD. THC and CBD are widely different in their biological makeup, but because they derive from the cannabis plant, regulators deemed both compounds to be unsafe for consumers. However, extensive research has uncovered that CBD provides therapeutic and health benefits, which then led to the rapid emergence of CBD-based products. As such, North American consumer spending on cannabis-infused foods and drinks reached USD 1.5 Billion in 2018, according to data compiled by Arcview Market Research and BDS Analytics, By 2022, the two firms suggest that edible sales are on track to reach USD 4.1 Billion.

Typically, most people consume CBD to simply relax. However, clinical trials have proven that CBD can also provide medical benefits. Specifically, patients suffering from chronic ailments such as severe pain, cancer, arthritis, and epilepsy can consume CBD drinks to subdue the symptoms. And while CBD is quickly permeating throughout global regions, the North American market is the primary driver because of legality stance. Canada moved to legalize cannabis entirely back in late 2018, which prompted a spur of recreational demand. On the other hand, the U.S. passed the Farm Bill in 2018, which legalized hemp-derived CBD products. Shortly after, stores across the nation began to commercialize CBD goods.

Now, consumers can easily purchase products such as tinctures, topicals, oils, and edibles at their local convenience stores or online e-commerce platforms. However, the CBD beverage market is one of the most popular segments because consumers can easily purchase a CBD-based tincture and add droplets of CBD into their beverage. Generally, CBD can be found within beverages such as soda, juice, coffee, wine, water, and even alcohol. However, consumers can also add CBD-based powders into their beverages and some producers have even mentioned that powders are much better in terms of solubility. Overall, the cannabis-infused beverage industry is quickly gaining traction, however, some beverage producers are still evaluating the industry.

Nonetheless, a handful of corporations such as the alcohol industry, have already dove into the marketplace and are already marking their presence.  “Everyone in the industry recognizes that CBD-infused beverages are going to be one of the largest category opportunities in all of CBD,” said Ben Witte, the Founder and Chief Executive Officer of Recess, a company producing CBD-infused sparkling water. “As a result of that, a lot of the suppliers in the supply chain have innovated to create a format that is soluble in beverages.”

Source: https://www.prnewswire.co.uk/news-releases/edible-cbd-products-offer-consumers-a-new-health-trend-884112693.html

NORTHBUD $NBUD.ca – ‘It is quite amazing’: #CBD oil entering the mainstream $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 10:26 AM on Friday, October 18th, 2019

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

NBUD: CSE
—————————–

‘It is quite amazing’: CBD oil entering the mainstream

By James Pugh

Some people are infusing the cannabis extract in cocktails, others are buying it in the form of dog treats, while many more are using it as a form of pain relief.

Unlike tetrahydrocannabinol, the psychoactive extract of the cannabis plant commonly known as THC, cannabidiol doesn’t cause users to get high.

And it is legal in the UK, assuming it does not contain one part in 10,000 of THC.

“When I first got involved with CBD I wanted to know what it was all about,” says Richard Butler, part of the management team at CBD Virtue, between Bridgnorth and Wolverhampton.

“It is still new in the UK.”

Some of the products

His company uses CBD to make products such as tablets, oils, body creams and balms.

Mr Butler says people are turning to CBD products to alleviate symptoms from physical ailments like pain and inflammation as well as mental ones like anxiety and depression.

At present, use of the oil is largely unregulated, and clinical trials into its usefulness are ongoing, but Mr Butler says he has witnessed its benefits.

“You learn more from the responses and feedback you get from customers,” he says. “It helps with pain relief, mental issues, anxieties.

“It also helps with eczema, psoriasis and acne – it is quite amazing actually.

“A lot of our initial customers were 40 plus and many were buying products for the younger generation.

Dean Burke using a CBD Pod Filler at CBD Virtue

“What has amazed me is the amount of depression and anxiety that exists among teenagers up to people in their late 20s.”

CBD oil, its proponents say, offers numerous benefits, from pain relief to reducing anxiety. As an anticonvulsant, it may also help treat neurological disorders such as epilepsy and multiple sclerosis.

CBD is also one of the biggest buzzwords in food and drink. It has been hailed the next big thing, with more and more chefs and producers using the products in their recipes.

After already taking other countries by storm, more businesses in the UK are looking to tap into the market.

Ross Burke viewing the product range at CBD Virtue

Mr Butler insists he has seen some significant success stories of people using the product for remedial purposes.

“I know someone who suffered with Parkinson’s for years who every time they woke up their whole body would be shaking and during the day they would shake out of control,” he says.

“I said ‘try this’ and within two weeks they went from their whole body shaking to feeling a slight twitch in their first finger and thumb.

“I am not allowed to say it cures cancer, but cancer sufferers are using it. There was someone who had skin cancer and it helped clear up blisters on their skin.

“My partner was on a lot of medication for various things and after taking four or five drops a day her stress and anxiety has gone.”

The product’s relationship to recreational cannabis also means that some people are reluctant to accept its use, and the medical benefits it provides have still to be proven beyond doubt.

But Mr Butler insists that the hemp-derived oil should be trusted.

“It is from a natural product that has been around for years,” he says. “Initially people were sceptical because it relates to cannabis. Yes, it is derived from cannabis plant, but the ‘high’ has been removed with the remedial side left behind.

The management team at CBD Virtue: Dean Burke, Richard Butler, Shannon Fyfe and Ross Burke

“We had the over 50s saying ‘ yeah but it’s cannabis, it’s cannabis’, but once you have explained to them they are willing to try it.

“A big part of my role has been educational. I would spend about two hours a day on Facebook educating people and answering a lot of questions.

“Initially it is getting people to try it, then after they see how effective it is they speak about it to their friends and family – a lot of it comes down to word of mouth.”

The plant is grown in Colorado in the USA, and a powdered form of the product is sent to the UK for the oil to be extracted by Richard’s team.

CBD Virtue employs 16 people, and is looking to double that by moving to larger premises to cope with demand.

Richard says: “We have a lab which is about 15ft by 20ft where a lot of our mixing is done. We also have another facility where we do the bottling up and everything else.

Jean Price packing up an order at CBD Virtue

“We are looking for larger premises due to growing demand and want to stay local. We employ 16 people and with the way things are going we are looking to double the workforce.”

Sales of products containing CBD have skyrocketed by 99 per cent in the UK, according to data.

Analysis by deals firm Wowcher suggests purchases of CBD products have almost doubled in 2019, with an increasing number of Brits trying the ingredient.

“The industry is exploding,” Mr Butler says. “Initially as a company we had a slow start with various issues with banks and online payment systems, but we have got more and more people on board who know how to get around these things.

Source: https://www.expressandstar.com/news/business/2019/10/17/it-is-quite-amazing-cbd-oil-entering-the-mainstream/

North Bud Farms $NBUD.ca Announces the Appointment of Sean Homuth as Acting Chief Financial Officer $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 10:03 AM on Thursday, October 17th, 2019
  • Announce the appointment of Sean Homuth as Acting Chief Financial Officer, effective today
  • Mr. Homuth’s permanent role as CFO will commence upon receiving Health Canada security clearance required for all Officers and Directors of the Company

TORONTO, Oct. 17, 2019 — North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) (“NORTHBUD” or the “Company”) is pleased to announce the appointment of Sean Homuth as Acting Chief Financial Officer (CFO), effective today. Mr. Homuth’s permanent role as CFO will commence upon receiving Health Canada security clearance required for all Officers and Directors of the Company. 

“As NORTHBUD expands its presence into the USA with the anticipated closing of its previously announced letters of intent with the Qlora Group (California) and Nevada Botanical Science (Nevada), we are strategically adding additional expertise in international business and finance,” said Ryan Brown, CEO of North Bud Farms Inc.

Mr. Homuth brings extensive experience with both Canadian and U.S. publicly traded organizations both in industry as well as from a client perspective during his tenure at Ernst & Young and, more recently, as an independent consultant. Previously, Mr. Homuth was Chief Financial Officer at Orezone Gold Corporation (and Vice President, Finance and Administration for its predecessor company, Orezone Resources Inc.) a publicly listed company headquartered in Canada with operations in West Africa. At Orezone Mr. Homuth led a global team of finance professionals and was involved in over $800 million in financings and M&A transactions with the company and its predecessor. Mr. Homuth holds accounting designations in both Canada (CPA, CA) and the United States (CPA – Illinois).

“We are pleased to welcome Sean to our dynamic team as NORTHBUD expands its footprint into the USA,” stated Ryan Brown, CEO of North Bud Farms Inc. “Sean brings specialty experience in accounting and finance for international companies as well as a profound knowledge of capital markets, having worked with and advised many public companies over the years. He joins NORTHBUD at an exciting time in its development as his leadership and experience will be essential in executing our strategic plan and taking the company to its next level of growth.”

Brendan Stutt, the Company’s incumbent CFO, who has made invaluable contributions to the Company’s financial leadership and culture, will work to ensure a smooth transition and will remain with the Company in a non-executive role.

Mr. Brown stated: “We would like to thank Brendan for his contributions to the Company, in particular the successful listing of NORTHBUD on the Canadian Securities Exchange.” 

About North Bud Farms Inc.
North Bud Farms Inc., through its wholly owned subsidiary GrowPros MMP Inc., is pursuing a licence under The Cannabis Act. The Company has built a state-of-the-art purpose-built cannabis production facility located on 135 acres of Agricultural Land in Low, Quebec, Canada. NORTHBUD through its wholly owned U.S. subsidiary, Bonfire Brands USA has entered into agreements to acquire assets in California and Nevada.

For more information visit: www.northbud.com

Neither the Canadian Securities Exchange (the “CSE”) nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements
Certain statements and information included in this press release that, to the extent they are not historical fact, constitute forward-looking information or statements (collectively, “forward-looking statements”) within the meaning of applicable securities legislation. Forward-looking statements, including those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management. This press release contains forward- looking statements including those relating to the entering into of the Definitive Agreement and closing of the Transaction with the Qlora Group and Nevada Botanical Science. Forward-looking statements are based on the reasonable assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect.

Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the risk factors included in the Company’s final long form prospectus dated August 21, 2018, which is available under the Company’s SEDAR profile at www.sedar.com. Accordingly, readers should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all of such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. The Company does not undertake any obligation to update any forward-looking statements to reflect information, events, results, circumstances or otherwise after the date hereof or to reflect the occurrence of unanticipated events, except as required by law including securities laws. This news release does not constitute an offer to sell or a solicitation of any offer to buy any securities of the Company.

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
North Bud Farms Inc.
Edward Miller
VP, IR & Communications
Office: (855) 628-3420 ext. 3
[email protected]

PODCAST: Why #cannabis 3.0 is the real opportunity for Canada with Bruce Linton – SPONSOR: #NORTHBUD $NBUD.ca $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 12:55 PM on Wednesday, October 9th, 2019

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

NBUD: CSE
—————————–

PODCAST: Why ‘cannabis 3.0’ is the real opportunity for Canada with Bruce Linton

By: Emily Jackson

Welcome to Down to Business, a weekly podcast from the Financial Post.

It’s been one year since Canada legalized the recreational cannabis industry after a century of prohibition. But it’s just the beginning of the journey from the black market to “cannabis 3.0.”

In the lead-up to the election, Down to Business has focused on business issues with a political twist. This week, host Emily Jackson discusses the cannabis industry’s one-year legalization anniversary with Bruce Linton, the former chief executive of Canopy Growth, Canada’s largest cannabis company.

Linton discusses lessons from the first round of legalization for recreational use, what to expect from the impending introduction of cannabis infused beverages and edibles, and why Canada needs to focus on “cannabis 3.0” if it wants to be a global leader.

You can listen below — or on Apple PodcastsSpotifyStitcher and Google Play, where you can also subscribe to get new episodes every Wednesday morning.

Source: https://business.financialpost.com/cannabis/cannabis-business/down-to-business-podcast-why-cannabis-3-0-is-the-real-opportunity-for-canada

NORTHBUD $NBUD.ca – As Canada gears up for pot 2.0, more shortages are on the menu $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 12:07 PM on Thursday, October 3rd, 2019

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

NBUD: CSE
—————————–
  • Canada’s legalization of pot edibles later this year is facing an even more shambolic start than the dried flower market, which is still struggling to meet demand, according to industry players.

Kristine Owram, Bloomberg News

Canada’s legalization of pot edibles later this year is facing an even more shambolic start than the dried flower market, which is still struggling to meet demand, according to industry players.

“At least that time we knew what the permissible product types were going to be and were already making them in the medical context,” said cannabis lawyer Trina Fraser, a partner at Brazeau Seller Law in Ottawa.

Canada will add edibles, extracts and topicals to the list of legal cannabis products no later than Oct. 17. Many analysts agree these products will generate better demand and margins than dried flower. But the federal government has not yet issued regulations for the new formats, making it difficult for producers to prepare lest they unknowingly violate some rule.

A spokeswoman for Health Canada declined to comment on when the regulations will be released.

In addition, a huge licensing backlog has built up at Health Canada, the government agency that oversees cannabis regulations. About 614 applications were waiting in the queue as of March 31.

“A full rollout amongst a nice wide array of producers and a wide array of these new product types is going to take time, literally years, because we have such a licensing backlog,” Fraser said.

Company Stockpiling

Canada’s market for edibles and other alternative pot produces will eventually be worth C$2.7 billion ($2 billion) annually, but consumers should expect “missteps, delays and frustration” in the early days, Deloitte said in a report published Monday. Jennifer Lee, Deloitte Canada’s cannabis national leader, estimated it will be a minimum of 24 months before the industry normalizes.

In the meantime, many pot companies are stockpiling, choosing to forgo revenue today to ensure they have enough supply for the new high-value products. This is exacerbating the shortage of dried flower, but executives say it’s worth it.

“We’ve made a very conscious effort to delay revenue,” said Chuck Rifici, chief executive officer of Auxly Cannabis Group Inc. Selling into the market today doesn’t build brand recognition because shelves are empty and consumers are buying whatever’s available, he added. “I would much rather save that product, get a multiple of margin on that brand and make sure that I have enough inventory.”

Lab Delays

This is proving to be a boon for extraction companies like Valens GroWorks Corp. Valens has contracts with many of the biggest pot companies, including Canopy Growth Corp., Hexo Corp. and Tilray Inc., to extract cannabis oil from their plants, which is then used for products like edibles and vape cartridges. It’s also investing heavily in its testing labs in the belief that Health Canada will have stringent regulations to ensure pesticides and other contaminants don’t make it into the new consumer products.

“Even in labs today there’s delays where people are waiting three weeks to a month to get lab results back and I think that will only get worse,” said Everett Knight, Valens’ executive vice president of strategy and investments.

Companies are also making big bets on what products will be in demand, with Canopy and Hexo leaning toward cannabis beverages and others toward vaping.

Be Prepared

“Why do I want an edible or a drink when I can have a vape?” Irwin Simon, interim CEO of Aphria Inc., said in an interview on the sidelines of a cannabis conference last month. “I see the margins and the opportunities there.”

Rifici at Auxly also believes vape pens will be “the most important category by far.” But there are many unanswered questions. For example, will the government require companies to engrave its mandatory THC warning symbol into the pen itself, or will a sticker suffice?

This is why Valens is offering its customers 196 different options for its white-label vape pens. “You’ve got to make sure you cover your bases and prepare for all the possibilities,” Knight said.

Despite the uncertainty, it’s better to be prepared even if plans and production lines have to be tweaked once the regulations come out, said Bruce Linton, CEO of Canopy, which is building a 197,000 square foot bottling plant for cannabis beverages in Smiths Falls, Ontario.

“We’re in a situation where it’s better to spend money to be ready than to save money and be late,” he said.

 Cannabis Canada is BNN Bloomberg’s in-depth series exploring the stunning formation of the entirely new – and controversial – Canadian recreational marijuana industry. Read more from the special series here and subscribe to our Cannabis Canada newsletter to have the latest marijuana news delivered directly to your inbox every day.

Source: https://www.bnnbloomberg.ca/as-canada-gears-up-for-pot-2-0-more-shortages-are-on-the-menu-1.1268844

North Bud Farms $NBUD.ca – A Budding Industry: #CBD Statistics & Trends (Infographic) $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 5:09 PM on Friday, September 27th, 2019

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

NBUD: CSE
—————————–

A Budding Industry: CBD Statistics & Trends (Infographic)

  • The sales of CBD are predicted to reach about $1.8 billion by 2022
  • At the moment, there are over 850 brands of CBD products in the US market
  • With over $1 billion, Colorado is the state with the highest cannabis revenues
  • Data on CBD user demographics show 40% of Americans are interested in trying CBD.

By Bojana Petkovic

What is CBD all about and why are cannabis and hemp oil all over the internet? To help you understand this rapidly growing industry, we’re going to present you with some interesting CBD statistics and facts.

CBD or cannabidiol is one of the most important active substances in the cannabis (marijuana) plant. It can be obtained from different cannabis species, but it can also be synthetically produced. There are divided opinions on whether it works better on its own or joined with other cannabis compounds, yet one thing is for sure — its positive effects on human (and pet) health are undeniable. At the moment, only CBD derived from hemp is legal under federal law while we wait for more research on the substance to begin.

We can observe CBD as an amazing cure, but we can also watch the changes in the industry. That is one serious venture and a lot of people would like to get a piece of that $20 billion pie (this is the prognosis for US sales of CBD by 2024).

With that in mind, here is our pick of:

Top 10 CBD Facts and Statistics

  • The sales of CBD are predicted to reach about $1.8 billion by 2022.
  • At the moment, there are over 850 brands of CBD products in the US market.
  • With over $1 billion, Colorado is the state with the highest cannabis revenues.
  • Data on CBD user demographics show 40% of Americans are interested in trying CBD.
  • A cannabis worker earns more than an average American.
  • The demand for employees in the CBD oil industry rose by 76% in one year.
  • Statistics on CBD direct sales show that the majority of direct sellers are women.
  • Women are founders or general managers of over 75% of CBD brands.
  • Pure CBD is perfectly safe for usage and you cannot get addicted to it.

See what we mean? Take a look at the following infographic for more mindblowing CBD trends.

Source: https://loudcloudhealth.com/cbd-statistics-infographic/